National Health Investors
193 hedge funds and large institutions have $2.31B invested in National Health Investors in 2017 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 92 increasing their positions, 53 reducing their positions, and 34 closing their positions.
74% more repeat investments, than reductions
Existing positions increased: 92 | Existing positions reduced: 53
12% more capital invested
Capital invested by funds: $2.07B → $2.31B (+$245M)
0.29% more ownership
Funds ownership: 70.89% → 71.18% (+0.29%)
6% less funds holding
Funds holding: 206 → 193 (-13)
26% less call options, than puts
Call options by funds: $4.54M | Put options by funds: $6.15M
38% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 34
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$24.9M |
| 2 |
Cohen & Steers
New York
|
+$22.7M |
| 3 |
Allianz Asset Management
Munich,
Germany
|
+$18.9M |
| 4 |
BlackRock
New York
|
+$16.5M |
| 5 |
B
Barings
Charlotte,
North Carolina
|
+$14.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OppenheimerFunds
New York
|
-$14.2M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$12M |
| 3 |
N
Nuveen
Charlotte,
North Carolina
|
-$11.4M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$10.7M |
| 5 |
MWNA
Marshall Wace North America
New York
|
-$6.79M |
NHI Hedge Fund Activity: Q2 2017 in Review
193 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in National Health Investors (NHI) for Q2 2017, worth a combined $2.31B — up 12% from $2.07B a quarter earlier.
Sellers outnumbered buyers: 34 funds closed out of NHI and 21 opened new positions — a net loss of 13 holders — while 53 trimmed existing stakes and 92 added.
The largest buyer was Goldman Sachs, adding an estimated $24.9M. The largest seller was OppenheimerFunds, exiting entirely with an estimated $14.2M sold.
- 193 institutional investors held National Health Investors (NHI) as of Q2 2017, down from 206 in Q1 2017.
- Funds reported $2.31B of National Health Investors stock for Q2 2017, up 12% quarter-over-quarter.
- 21 funds opened new National Health Investors positions in Q2 2017 and 34 closed out, a net change of -13 holders.
- The largest National Health Investors buyer in Q2 2017 was Goldman Sachs, an estimated $24.9M added.
- The largest National Health Investors seller in Q2 2017 was OppenheimerFunds, an estimated $14.2M sold.
Based on aggregated 13F filings for Q2 2017.